These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19743577)

  • 21. HPV vaccine effect: is the glass half full or half empty?
    Saraiya M; Hariri S
    Lancet; 2011 Jun; 377(9783):2057-8. PubMed ID: 21684367
    [No Abstract]   [Full Text] [Related]  

  • 22. Writing for PRO position: Should the HPV vaccine be mandatory for early adolescent girls?
    Cruise E
    MCN Am J Matern Child Nurs; 2007; 32(4):208. PubMed ID: 17667281
    [No Abstract]   [Full Text] [Related]  

  • 23. Latin America. Price is the main barrier to wider use of papillomavirus vaccine.
    Kaiser J
    Science; 2008 May; 320(5878):860. PubMed ID: 18487164
    [No Abstract]   [Full Text] [Related]  

  • 24. Human papillomavirus vaccine: waiting for a miracle.
    MacDonald N; Hébert PC
    CMAJ; 2007 Aug; 177(5):433, 435. PubMed ID: 17724313
    [No Abstract]   [Full Text] [Related]  

  • 25. Bandicoots, bonobos, and boys: papillomavirus and vaccination strategies.
    Grose C
    Pediatrics; 2009 Apr; 123(4):1244-5. PubMed ID: 19336384
    [No Abstract]   [Full Text] [Related]  

  • 26. Questions remain about the human papillomavirus vaccine.
    Printz C
    Cancer; 2009 Feb; 115(4):699-701. PubMed ID: 19189370
    [No Abstract]   [Full Text] [Related]  

  • 27. [Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme].
    de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2639-40; author reply 2640-1. PubMed ID: 19105259
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention, diagnosis, and treatment of cervical cancer.
    Long HJ; Laack NN; Gostout BS
    Mayo Clin Proc; 2007 Dec; 82(12):1566-74. PubMed ID: 18053467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the HPV vaccine: researchers confront complex interplay of factors.
    Tuma RS
    J Natl Cancer Inst; 2009 Apr; 101(7):444-5. PubMed ID: 19318636
    [No Abstract]   [Full Text] [Related]  

  • 30. Human papillomavirus vaccine.
    Suba EJ; Raab SS;
    N Engl J Med; 2007 Sep; 357(11):1155; author reply 1155-6. PubMed ID: 17874469
    [No Abstract]   [Full Text] [Related]  

  • 31. Cervical cancer: the second-generation vaccines move forward.
    Tuma RS
    J Natl Cancer Inst; 2009 Jun; 101(11):774-5. PubMed ID: 19470948
    [No Abstract]   [Full Text] [Related]  

  • 32. Broad-spectrum human papillomavirus vaccines: new horizons but one step at a time.
    Bosch FX
    J Natl Cancer Inst; 2009 Jun; 101(11):771-3. PubMed ID: 19470950
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and success of the human papillomavirus vaccine: time for a robust vaccination program in the United States and worldwide.
    Duska LR
    Clin Ther; 2014 Jan; 36(1):4-7. PubMed ID: 24417780
    [No Abstract]   [Full Text] [Related]  

  • 34. Controversy over cervical cancer vaccine spurs safety surveillance.
    Keim B
    Nat Med; 2007 Apr; 13(4):392-3. PubMed ID: 17415361
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy data and HPV vaccination studies.
    Baylor NW; Wharton M
    JAMA; 2009 Dec; 302(24):2658-9; author reply 2659-60. PubMed ID: 20040548
    [No Abstract]   [Full Text] [Related]  

  • 36. Vaccines against papillomavirus infections and disease.
    Villa LL
    Rev Chilena Infectol; 2006 Jun; 23(2):157-63. PubMed ID: 16721451
    [No Abstract]   [Full Text] [Related]  

  • 37. HPV "coverage".
    Schuchat A
    N Engl J Med; 2015 Feb; 372(8):775-6. PubMed ID: 25693018
    [No Abstract]   [Full Text] [Related]  

  • 38. [Vaccine against human papillomavirus. The Danish Society of Gynecology and Obstetrics].
    Kjaer SK
    Ugeskr Laeger; 2006 Mar; 168(12):1218. PubMed ID: 16571309
    [No Abstract]   [Full Text] [Related]  

  • 39. Playing games with girls' health: why it is too soon to mandate the HPV vaccine for pre-teen girls as a prerequisite to school entry.
    Gendel JE
    Seton Hall Law Rev; 2009; 39(1):265-90. PubMed ID: 19288617
    [No Abstract]   [Full Text] [Related]  

  • 40. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
    Knudtson M; Tiso S; Phillips S
    Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.